Page last updated: 2024-12-05

phenylisothiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenylisothiocyanate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phenyl isothiocyanate : An isothiocyanate having a phenyl group attached to the nitrogen; used for amino acid sequencing in the Edman degradation. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7673
CHEMBL ID309036
CHEBI ID85103
SCHEMBL ID20984
MeSH IDM0046991

Synonyms (77)

Synonym
CHEMBL309036
isothiocyanato-benzene
chebi:85103 ,
EN300-17278
isothiocyanic acid phenyl ester
phenylsenfoel
isothiocyanatobenzene
thiocarbanil
103-72-0
benzene, isothiocyanato-
wln: scnr
nsc5583
isothiocyanic acid, phenyl ester
phenyl thioisocyanate
benzene-1-isothiocyanate
nsc-5583
usaf m-4
phenyl isothiocyanate
ai3-09310
phenylisothiocyanate
nsc 5583
einecs 203-138-1
fenylisothiokyanat [czech]
ccris 3144
phenylsenfoel [german]
brn 0471392
pitc
inchi=1/c7h5ns/c9-6-8-7-4-2-1-3-5-7/h1-5
phenyl isothiocyanate, sigma grade, 8.36 m, suitable for solid phase protein sequencing analysis, >=99% (gc), liquid
phenyl isothiocyanate, reagent grade, 98%
phenyl isothiocyanate, 99%, for protein sequencing
I0191
AKOS000119287
A800790
NCGC00248931-01
4-12-00-00867 (beilstein handbook reference)
0d58f84lsu ,
unii-0d58f84lsu
fenylisothiokyanat
dtxcid501129
cas-103-72-0
NCGC00258680-01
tox21_201128
dtxsid0021129 ,
akos bbs-00004438
STL281854
FT-0627519
phenyl isothiocyanate [mi]
AM90356
BBL027476
SCHEMBL20984
isothiocynato benzene
phenyl-isothiocyanate
phenyl isothiocynate
phenyl isothio-cyanate
1-isothiocyanatobenzene
phenylisothiocynate
phenyisothiocyanate
isothiocynatobenzene
bdbm50073665
J-802269
ylothane
J-523934
phenyl sothocyanate
J-801008
F2121-0322
phenyl isothiocyanate, for protein sequence analysis, >=99.5% (gc)
mfcd00004798
CS-B1640
BCP22726
Q422311
FS-4271
D77304
phenyl isothio cyanate
phenylisothiocyanate phenolic
phenylisothiocyanate1533
Z56904678

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" A particular application of this method was exemplified by the dosage of enkephalins secreted from perfused bovine adrenal glands."( Sensitive method of detection, quantitation and purification of peptides using pre-column derivatization with phenyl isothiocyanate.
Dumont, M; Lemaire, S; Nolet, S, 1988
)
0.27
"A selective and specific high performance liquid chromatography method was developed to quantitate glucosamine hydrochloride in raw materials, dosage forms and plasma."( Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms and plasma using pre-column derivatization with ultraviolet HPLC.
Adebowale, A; Ashraf, M; Eddington, ND; Leslie, J; Liang, Z, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
isothiocyanateAn organosulfur compound with the general formula R-N=C=S.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency65.33070.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency50.14220.006038.004119,952.5996AID1159521; AID1159523
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency50.00130.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency51.52670.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency70.82770.001530.607315,848.9004AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency63.12530.005428.02631,258.9301AID1346982
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency56.70680.023723.228263.5986AID743223
heat shock protein beta-1Homo sapiens (human)Potency63.62610.042027.378961.6448AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency56.26040.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Macrophage migration inhibitory factorHomo sapiens (human)IC50 (µMol)11.00000.03803.09109.8000AID1198788
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1105127Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1198788Inhibition of macrophage migration inhibitory factor tautomerase activity in human Jurkat T cells using L-dopachrome methyl ester as substrate incubated for 30 mins prior to substrate addition measured for 2 mins by spectrophotometric analysis2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID34978Compound was tested for % inhibition against RLAR (aldose reductase) at a concentration of 10 micro M.1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
AID1105233Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 836 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105234Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 585 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105202Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 585 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID34979Compound was tested for % inhibition against RLAR (aldose reductase)at a concentration of 10 uM, pre-incubated with 100 uM sorbinil1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
AID1105136Fungitoxic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2508 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252689Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1105093In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 168 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105167Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 251 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105200Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 836 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105094In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 84 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692255Induction of p53 G245C mutant depletion in human NCI-H596 cells at 20 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1687062Inhibition of Escherichia coli MurA using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite green colorimetric assay2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105116Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 42 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105125Fungistatic activity in Sclerotinia sclerotiorum assessed as sclerotial viability measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105132Fungistatic activity in Sclerotinia sclerotiorum assessed as viability in volatile phase at 418 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687064Inhibition of Staphylococcus aureus MurA expressed in Escherichia coli assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite gr2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1687066Inhibition of Escherichia coli MurA assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins in presence of 5 mM cysteine by malachite green co2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105115Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 84 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105199Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1672 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105108Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 418 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687067Inhibition of recombinant cathepsin B (unknown origin) endopeptidase activity expressed in Escherichia coli assessed as residual activity at 100 uM using Z-RR-AMC as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine followed by2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105235Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 418 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105176Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 84 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692257Induction of covalent cysteine modification at p53 G245C mutant in human NCI-H596 cells at 100 uM incubated for 1 hr by monochlorobimane fluorometric assay2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1687068Inhibition of recombinant cathepsin B (unknown origin) exopeptidase activity expressed in Escherichia coli assessed as residual activity at 100 uM using Abz-GIVRAK(Dnp)-OH as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine fo2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105150Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 836 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105245Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 42 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105177Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 42 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105166Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 418 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105140Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1672 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692256Induction of p53 R280K mutant depletion in human MDA-MB-231 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1687065Inhibition of Escherichia coli MurA assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite green colorimetric assay relative to 2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1656234Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay2019European journal of medicinal chemistry, Feb-15, Volume: 164Green recipes to quinoline: A review.
AID1105106Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 836 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105126Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105198Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2508 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687069Inhibition of recombinant cathepsin X (unknown origin) expressed in Pichia pastoris assessed as residual activity at 100 uM using Abz-Fek(Dnp)-OH as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine followed by substrate additi2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105244Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 84 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105165Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 836 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105201Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 752 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (209)

TimeframeStudies, This Drug (%)All Drugs %
pre-199076 (36.36)18.7374
1990's69 (33.01)18.2507
2000's29 (13.88)29.6817
2010's32 (15.31)24.3611
2020's3 (1.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.98 (24.57)
Research Supply Index5.43 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index78.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (3.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other219 (96.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]